Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third-line Helicobacter pylori eradication with sitafloxacin, amoxicillin and vonaprazan
jRCTs031180413Completed
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan, amoxicillin and sitafloxacin in Helicobacter pylori infection. Primary endpoint: The efficacy of eradication treatment. Started May 2016; status: completed.
02
Drugs
vonoprazanamoxicillinsitafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031180413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180413.